HPGC Renmintongtai Pharmaceutical Corporation's low P/E rati...

HPGC Renmintongtai Pharmaceutical Corporation's low P/E ratio may be due to anticipated significant degradation in earnings performance. The company's recent three-year growth being lower than market forecast also contributes to the low P/E. These trends may prevent a strong rise in share price soon.